Julie Johnson (D-TX)

PAAT Act

H.R. 5467 · House bill Health

A Democratic bill with 1 Republican cosponsor · See all 5 cosponsors

Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill, known as the "Patient Access to Autoimmune Treatments Act" or the "PAAT Act," seeks to amend the Social Security Act. It would require Medicare Part D prescription drug plans to include coverage for drugs used to treat autoimmune diseases, hemophilia, or Von Willebrand disease. This coverage requirement would begin in 2027 and continue for each subsequent year. Additionally, the bill aims to restrict how much prior authorization is required for these specific drugs.

Yes· 3 of 5

  • Scored +6

    Would people over 65 be better off under this?

    The bill ensures Medicare Part D coverage for autoimmune and blood disorder treatments starting in 2027.

  • Scored +6

    Would retired people be better off under this?

    The bill provides guaranteed coverage and reduces administrative hurdles for Medicare-eligible patients with specific conditions.

  • Scored +5

    Does this put more money into Medicare, the health coverage for people over 65?

    The bill mandates Medicare Part D plans to cover specific drugs for autoimmune diseases and blood disorders.

The opposite

No question was scored the opposite.